A Proposed Clinical Trial Model: Analyzing the CT Process
This new model standardizes data exchange between the various stages of a research study.
India: Have We Made Progress?
Closing Thoughts on the state of clinical trials in India today.
eShowcase
Tools for Clinical Trials Professionals
The Imperative to Support Site Adoption of EDC
Lack of adequate and attentive support is preventing some sites from fully taking advantage of EDC and ePRO technologies.
Clinical Inspections, IRBs Face Overhaul
Changes prompt new oversight approaches by FDA and research institutions.
The Globalization of Clinical Trials
As some EU countries struggle with the Directive's regulatory demands, emerging markets such as China, India, and Russia continue to bolster their clinical research and drug development programs.
Good Regulatory Practices: Another Set of "Things to Do"?
GRPs are not another set of guidelines or "additional hurdles" prepared by authorities.
Two-Timing on Today's Vaccines?
New paper from the European Medicines Agency explores future vaccine guideline.
Trial Organizers Must Involve More Older People in Research
Prof. Marion E.T. McMurdo elaborates on the importance of including older subjects in clinical trials.
